Influenza vaccination in 2026: a new era of protection

Date: Thursday 5 March 2026
Time: 12.00–1.30 p.m. (AEDT)

Register here

Get ready for 2026 influenza vaccination with the latest insights, guidance and practical tips from leading experts.

Following unusually high numbers of out‑of‑season influenza cases across both hemispheres, increasing vaccination uptake will be critical in 2026. Without improved vaccine uptake, vulnerable Australians, including babies, young children and older adults, face an increased risk of serious illness and hospitalisation.

This webinar brings together the latest evidence on influenza burden and vaccination coverage, alongside expert insights into what to expect in the upcoming season. It will also provide important updates on influenza vaccines available in Australia in 2026, including the introduction of the live attenuated influenza vaccine (LAIV), which will be available and funded for the first time through some state and territory programs.

Expert speakers will outline key considerations for immunisation providers, share recent trends in Australian and global influenza virus circulation, and provide you with practical guidance to support vaccine delivery and effective conversations with patients.

The webinar will cover:

• recent trends in influenza burden and vaccine coverage
• the 2026 National Immunisation Program and state-based influenza vaccination programs 
• influenza vaccines available in Australia in 2026, including LAIV
• practical strategies for administrating LAIV, and for responding to common patient questions.

Can’t make it live? You can catch up later – the webinar will be recorded and made available on the NCIRS website. Register now to receive the link straight to your inbox once it’s ready.